132 related articles for article (PubMed ID: 1282924)
41. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms.
Steck K; el-Naggar AK
Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161
[TBL] [Abstract][Full Text] [Related]
42. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
43. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
44. Quantitative cell-cycle protein expression in oral cancer assessed by computer-assisted system.
Soares CP; Zuanon JA; Teresa DB; Fregonezi PA; Neto CB; Oliveira MR; Donadi EA; Martinelli-Kläy CP; Soares EG
Histol Histopathol; 2006 Jul; 21(7):721-8. PubMed ID: 16598671
[TBL] [Abstract][Full Text] [Related]
45. [Expression of proliferating cell nuclear antigen (PCNA) in squamous cell carcinoma of the oral cavity].
Qiao B; Wu Q; Wu D
Zhonghua Kou Qiang Yi Xue Za Zhi; 1995 Jan; 30(1):21-2, 63-4. PubMed ID: 7789227
[TBL] [Abstract][Full Text] [Related]
46. Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data.
Fontanini G; Pingitore R; Bigini D; Vignati S; Pepe S; Ruggiero A; Macchiarini P
Am J Pathol; 1992 Dec; 141(6):1285-90. PubMed ID: 1361306
[TBL] [Abstract][Full Text] [Related]
47. Proliferative activity in the malignant cellular blue nevus.
Pich A; Chiusa L; Margaria E; Aloi F
Hum Pathol; 1993 Dec; 24(12):1323-9. PubMed ID: 7903955
[TBL] [Abstract][Full Text] [Related]
48. Agnor as a marker of malignant transformation in odontogenic keratocysts.
Piloni MJ; Keszler A; Itoiz ME
Acta Odontol Latinoam; 2005; 18(1):37-42. PubMed ID: 16302459
[TBL] [Abstract][Full Text] [Related]
49. Proliferating cell nuclear antigen (PCNA) as a marker of dysplasia in oral mucosa.
Martínez-Lara I; González-Moles MA; Ruiz-Avila I; Bravo M; Ramos MC; Fernández-Martínez JA
Acta Stomatol Belg; 1996 Mar; 93(1):29-32. PubMed ID: 8986050
[TBL] [Abstract][Full Text] [Related]
50. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
[TBL] [Abstract][Full Text] [Related]
51. Methods in pathology. Optimization of proliferating cell nuclear antigen immunohistochemical staining by microwave heating in zinc sulfate solution.
Shin HJ; Shin DM; Shah T; Ro JY
Mod Pathol; 1994 Feb; 7(2):242-8. PubMed ID: 7516561
[TBL] [Abstract][Full Text] [Related]
52. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker.
Shin DM; Voravud N; Ro JY; Lee JS; Hong WK; Hittelman WN
J Natl Cancer Inst; 1993 Jun; 85(12):971-8. PubMed ID: 8098774
[TBL] [Abstract][Full Text] [Related]
53. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
Delahunt B; Bethwaite PB; Thornton A; Ribas JL
Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
[TBL] [Abstract][Full Text] [Related]
54. Assessment of proliferating cell nuclear antigen (PCNA) expression at the invading front of oral squamous cell carcinoma.
Lu EM; Ratnayake J; Rich AM
BMC Oral Health; 2019 Oct; 19(1):233. PubMed ID: 31672124
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the nucleolar organizer region associated proteins in oral squamous cell carcinoma.
Epivatianos A
Ann Dent; 1994; 53(1):33-6. PubMed ID: 8060107
[TBL] [Abstract][Full Text] [Related]
56. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
[TBL] [Abstract][Full Text] [Related]
57. Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections.
Korkolopoulou P; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
Am J Surg Pathol; 1993 Sep; 17(9):912-9. PubMed ID: 8102513
[TBL] [Abstract][Full Text] [Related]
58. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
Narita T; Funahashi H; Satoh Y; Takagi H
Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
[TBL] [Abstract][Full Text] [Related]
59. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
60. A comparison of cellular proliferation markers in squamous cell carcinoma of the head and neck.
Jones AS; Roland NJ; Caslin AW; Cooke TG; Cooke LD; Forster G
J Laryngol Otol; 1994 Oct; 108(10):859-64. PubMed ID: 7989834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]